Board of Directors

Proven leadership guides Centice Corporation’s pursuit of innovative products and services

At all levels of our organization, Centice Corporation relies on driven, forward-thinking individuals to define our direction. Discover More… about the leaders who help us realize our vision and achieve success.

Scott Albert
Chairman of the Board
Tom Scholl
Aidar Gabidullin
David Brady, PhD

Scott Albert

Chairman of the Board
Managing General Partner, The Aurora Funds, Inc.

Scott Albert co-founded The Aurora Funds with Jeff Clark in 1994, after already spending nearly a decade in the venture capital industry. Having also spent time as an entrepreneur, he wanted to create an entrepreneurs-friendly venture capital firm that could offer hands-on support and guidance, in addition to funding. Today, he leads the IT investment team at Aurora and also oversees much of the day-to-day management of the firm. Prior to forming The Aurora Funds, Scott was the Chief Investment Officer of the North Carolina Technological Development Authority, Inc. (“NCTDA”), a state-funded corporation that supports technology-based entrepreneurial companies in North Carolina. While there, he led the new venture investment efforts and performed portfolio company monitoring for the NCTDA’s extensive statewide portfolio. Prior to serving at the NCTDA, he was at Criterion Venture Partners in Houston, Texas, as a General Partner for a $30 million pool of capital, and with Golder, Thoma and Cressey, in Chicago. In addition, he has served as President of a venture-backed start-up company. Before entering the venture capital industry, he was a consultant for Booz, Allen and Hamilton. During his venture capital career, Scott has helped close more than 40 investment deals, including a broad range of Information Technology and Life Science companies. Scott currently serves on the boards of several Aurora portfolio companies, including ALN Medical Management, Centice, StrikeIron and TriVirix. Scott was previously on the boards of Solution Technology (acquired by Rodel) and DataFlux (acquired by SAS) and led the investment in Blackboard (NASDAQ: BBBB). Scott has a bachelor’s of science in Engineering from Duke University and a MBA from the University of Chicago.

Tom Scholl

General Partner, Novak Biddle Venture Partners

Tom is a successful entrepreneur and investor with experience sitting on both sides of the boardroom table. He has over twenty-five years experience in communications systems, equipment, chipsets and software, and has been active in the high-tech start-up scene in the Washington metro area for over 15 years.

He currently sits on the boards of Novak Biddle portfolio companies Centice, Paratek, Princeton Optronics, Command Information, Fiberzone Networks, Digital Bridge and Avail Media.

In 1990, Tom founded Telogy Networks, a leader in providing embedded communications software products for wireless and IP networks. Telogy’s award-winning products were proven market successes with world-class customers such as Cisco, Motorola, Samsung, Nortel, Alcatel and NEC. In 1998, Motorola purchased Telogy’s digital cellular technology and development team for over $40M, and in 1999, Texas Instruments purchased Telogy as the leader in embedded VOIP software for over $700M.

Prior to joining Novak Biddle, Tom co-founded and was chairman of Cognio, a developer of spectrum management and MIMO antenna technology for wireless applications. Cognio was acquired by Cisco in October 2007. Tom has also served as a Director of Torrent Networking, acquired by Ericsson, and Integrated Telecom, acquired by PMC Sierra.

In 1995, Tom was recognized as the Joseph A. Sciulli “Entrepreneur of the Year” by the Maryland High Technology Council. Prior to Telogy, Tom was Senior Vice President of Engineering at Hughes Network Systems, a combination of M/A-Com DCC and Linkabit.

Tom is a member of the Board of Trustees at the University of Maryland and Chairman of the Board of Visitors at the Clark School of Engineering. He is also a member of the Dean’s Advisory Council of the College of Liberal Arts at Purdue University.

Tom has patents relating to software, the Internet, and digital telephone systems, and he is the author of “Packet Switching” in McGraw Hill’s Electronic Communications Handbook. He’s a member of IEEE and ACM, and he is an alumnus of Purdue University and the Executive Management (non-dgree) program at MIT Sloan School.

Aidar Gabidullin

Oscriva LtdBio

Aidar Gabidoullin is a Partner of S-Group Capital Management, with responsibility for financial and high-growth technology companies. He has extensive experience both in acquisitions and in strategic and operational management of high-growth companies in the financial and high-tech industries.

Prior to joining S-Group Capital Management, Aidar worked for Andersen Consulting in London, McKinsey & Co. in Russia and Capital One in the United States. Aidar is on the board of directors of five companies located in Russia, the US and Europe.

Mr. Gabidoullin graduated from the Moscow Institute of Physics and Technology and holds an MBA degree from the INSEAD Business School (France).

David Brady, PhD

Chief Scientist and Co-Founder, Centice Corporation

David Brady holds a B.A. in physics and mathematics from Macalester College and M.S. and Ph D degrees in applied physics from the California Institute of Technology. He was on the faculty of electrical and computer engineering at the University of Illinois in Urbana-Champaign from 1990 until joining the Duke faculty as founding director of the Fitzpatrick Institute for Photonics in 2001. Professor Brady leads the Duke Imaging and Spectroscopy Program (www.disp.duke.edu), which builds computational optical sensors for hyperspectral imaging, 3-D microscopy, molecular imaging and chemometrics and wide field cameras. Dr. Brady is the author of Optical Imaging and Spectroscopy (OSA-Wiley 2009) and is a fellow of the Optical Society of America, SPIE and IEEE.

Discover More… about Centice Corporation

Executive Team

Proven leadership guides Centice Corporation’s pursuit of innovative products and services

Scott Albert
Chairman of the Board and Chief Executive Officer
Managing General Partner, The Aurora Funds, Inc.
Arthur Bergens
Chief Financial & Administration Officer
John Davis
Vice President, Sales and Marketing
Prasant Potuluri, Ph. D.
Chief Technology Officer

Scott Albert

Chairman of the Board and Chief Executive Officer
Managing General Partner, The Aurora Funds, Inc.

Scott Albert was appointed President and CEO in June of 2009, having been a lead investor of Centice and serving on the company’s Board of Directors since its founding in the summer of 2004. Mr. Albert brings a unique combination of executive, operational, investment and financial experience to Centice, having worked with over fifty venture backed companies in the technology and medical areas throughout his career.

Mr. Albert co-founded The Aurora Funds, Inc., a lead investor in Centice, in 1994, after already spending nearly a decade in the venture capital industry. Today, he leads the IT investment team at Aurora and also oversees much of the day-to-day management of the firm. Prior to forming The Aurora Funds, he was the Chief Investment Officer of the North Carolina Technological Development Authority, Inc. (“NCTDA”), a state-funded corporation that supports technology-based entrepreneurial companies in North Carolina. While there, he led the new venture investment efforts and performed monitoring for the NCTDA’s extensive statewide portfolio. Prior to serving at the NCTDA, he was at Criterion Venture Partners in Houston, Texas, as a General Partner for a $30 million pool of capital, and with Golder, Thoma and Cressey, in Chicago. In addition, he served as President of a venture-backed start-up company in Houston, Texas. Before entering the venture capital industry, he was a consultant for Booz, Allen and Hamilton. Mr. Albert currently serves on the boards of several other Aurora portfolio companies, including ALN Medical Management, StrikeIron, TriVirix and Unitrends. He was previously on the boards of Solution Technology (acquired by Rodel) and DataFlux (acquired by SAS) and led Aurora’s investment in Blackboard (NASDAQ: BBBB). Mr. Albert has a bachelor’s of science in Engineering from Duke University and an MBA from the University of Chicago.

Arthur Bergens

Chief Financial & Administration Officer

Arthur Bergens became CFO of Centice in January 2006, boasting more than 20 years of experience in a wide range of financial leadership positions. Prior to joining Centice, he served as CFO for Unitive, Inc., a leader in advanced wafer packaging solutions for the semiconductor industry. Unitive was acquired in August 2004 by Amkor Technology, Inc. (NASDAQ: AMKR), a publicly held company and one of the world’s leading providers of contract semiconductor manufacturing, assembly and test services. At Amkor, Arthur held the title of Vice President of Finance and Administration, making him responsible for financial leadership of Amkor’s new Wafer Level Packaging Business Unit.

Before working with Unitive, Arthur was Vice President and CFO for the Americas Region at Modus Media International, Inc., a global provider of supply chain management solutions to the high technology industry, with annual revenues of some $600 million. Arthur has served as CFO for TANO Automation, Inc., which develops, engineers and manufactures microprocessor-based control systems for the marine, oil, gas, water and wastewater industries. Arthur has also held the position of manager in the New Orleans office of Ernst & Young.

Arthur holds a MBA from Campbell University and a bachelor’s degree in accounting from the University of New Orleans, and is a licensed certified public accountant in both Louisiana and North Carolina.

John Davis

Vice President, Sales & Marketing

John Davis offers more than 19 years of senior-level sales and marketing experience in the pharmaceutical and healthcare arenas. Considered a pharmacy domain expert, John remains committed to improving pharmacy operations and safety. While at Innovation, a leader in the pharmacy automation and workflow arena, he built a successful international sales force that spanned all the primary pharmacy market segments. He was Director of Sales, Pharmaceutical Distribution and Regional Sales Manager for Cardinal Health’s Atlantic region. During his tenure at Cardinal Health, John was continually recognized for his strong leadership and team-building skills and for leading sales growth, profitability and sales revenue. He has also held senior-level sales positions with McKesson HBOC and FoxMeyer Corporation. He is a member of multiple industry associations, including ASHP, NACDS and NCPA. John holds a bachelor’s of science degree in business administration from the University of Pittsburgh.

Prasant Potuluri, Ph. D.

Chief Technology Officer

Dr. Prasant Potuluri is the Chief Technology Officer at Centice Corporation, primarily focusing on identifying and evaluating new technology and providing strategic vision and direction to the engineering group. He has pursued several federal grants for Centice and has won close to $1.4 million in research funds. He also strategically manages the Intellectual portfolio of the company.

Prior to co-founding Centice in 2004, Prasant was a graduate research assistant at Duke University and developed the company’s core computational sensor technology platform. His PhD thesis—titled “Multiplexed Optical Sensors for Reference Structure Tomography and Compressive Spectroscopy“—was the first demonstration of compressive sampling, a revolutionary concept. In 2004, Prasant was awarded the John T. Chambers Fellow for demonstrating excellence in classroom activities, research activities and for participation in Duke Activities. Prasant played a critical role in winning the grand prize at the Duke Startup Challenge.

Dr. Potuluri obtained a PhD from Duke University, a master’s degree from University of Illinois at Urbana-Champaign and a bachelor’s degree in Technology from the Indian Institute of Technology, Bombay. He is a member of the Optical Society of America, SPIE and Sigma-Xi. He founded the Duke Chapter of the Optical Society of America and held the office of the President for the chapter during 2003-2004.

Discover More… about Centice Corporation

Director, Information Technology

Job Description

The Director of Information Technology will be responsible for managing IT Operations, and for developing and implementing the IT strategy for the enterprise IT infrastructure to support the internal and external business requirements. This person is also responsible for managing the IT partners, vendors and a future staff of technical professionals to own the IT infrastructure, including networking, telecommunications, backup and recovery, reporting, and desktop services. This person is responsible for developing work plans, resource planning, budgeting, execution, and management for all IT operations. This position reports to the Chief Financial and Administrative Officer.

The ideal candidates must have the following qualifications:

Bachelor’s degree in Computer Science or related field; advanced degree preferred
10+ years experience in IT strategic planning and execution leadership role with minimum of 5-7 years of wide-area networking
Specific technologies needed include:
- Windows, SQL servers
- Active Directory Design and Maintenance
- WAN, Internet, Extranet
- Cisco routers
- Firewalls, Security
- Exchange 2003
- MCSE required
- CCNA required, CCNP a plus
Current, hands-on experience supporting network, server and desktop infrastructure
Proven track record in leading and influencing senior-level executives and cross-functional teams
Proficient problem analysis, measurement, and process methodology skill set
Exceptional leadership, prioritization, and project management skills
Experience in cross-functional IT planning and administration-type functions, including extensive contract interpretation and negotiation skills
Exceptional written and verbal communication skills

A spinout of Duke University and backed by the Aurora Funds and Novak Biddle groups. We are a multidisciplined team that designs and manufactures novel molecular sensors for the pharmaceutical and medical markets. Centice is a home for people with passion and talent. We welcome applicants who thrive on responsibility and wish to make a difference, working in an environment that fosters creativity and learning, and measures the success of our execution by the results that we generate. To apply, please paste your resume in the message field of your e-mail. In the subject line of the e-mail, please include your name and the position you are applying for.

~~Apply Online~~

Return to main Careers page

Please Note: Centice does not accept unsolicited resumes from external agencies with which we do not have an existing relationship. Any third-party resume forwarded by recruiters will be considered property of Centice and treated as a direct application. This exchange does not constitute an agreement between Centice and the recruiter. Centice reserves the right to contact the candidate directly; recruiters will receive no compensation from Centice.

Careers

Help shape the pharmaceutical safety industry by embarking on a career with us

Centice Corporation helps people do amazing things – and we want to enable our employees to do amazing things too. We are a dynamic, fast-paced organization providing an environment of individual responsibility with a problem-solving focus.

We are seeking individuals who embrace the challenge of bringing innovative products to market and building a dynamic and enduring company. Centice looks for talent who exude excellence and enthusiasm to adjoin their valuable expertise to our high quality team.

Discover More… professional opportunities at Centice Corporation

Current Openings:

Thank you for your interest in working with us. There are no current open positions available.

Apply Online

To apply, please paste your resume in the message field of your e-mail. In the subject line of the e-mail, please include your name and the position you are applying for. Apply Now.

Benefits Provided

In addition to a dynamic work environment, we also offer a competitive compensation and benefits package. Click here for more information.

What our employees have to say

“I joined Centice because the cutting edge technologies that Centice has been creating to improve the quality and efficiency of dispensed medications strongly appealed to me. The success and reputation of Centice drove me to dedicate my knowledge and experience to the company – I feel privileged to have the opportunity to work for Centice. Furthermore, I am excited to work with such enthusiastic, collaborative, and high-energy teams, which was another important factor in deciding to join Centice – to achieve common goals and accomplish my dreams.”
Yuting Qi, PhD, Research Scientist

Discover More… about Centice Corporation

Investors

A strong group of forward-thinking investors help propel Centice into the future

Centice Corporation’s efforts to bring cutting-edge optical sensor technology to the pharmaceutical market have been backed by venture capital investments from a number of notable firms. Discover more… about our investors.

THE AURORA FUNDS

Founded in 1994, The Aurora Funds is a venture capital firm that provides capital, connections and strategic guidance to entrepreneurs with early-stage health care, life sciences and information technology companies in the southeastern and mid-Atlantic United States. The firm manages more than $230 million in five venture funds. For more information, visit www.aurorafunds.com.

NOVAK BIDDLE VENTURE PARTNERS

Novak Biddle Venture Partners is a leading early-stage venture capital firm focused on unique, cutting-edge technology investments in the eastern United States, as well as targeted opportunities nationwide. With $580 million under management, Novak Biddle operates five venture funds that currently provide equity financing and management assistance to 42 portfolio companies. Novak Biddle continues to seek business situations where the combination of ideas, dollars, experience and relationships can create long-term, sustainable value. For more information, visit www.novakbiddle.com.

S-GROUP DIRECT INVESTMENTS LTD.

Founded in 2006, S-Group Direct Investments Ltd. is a private equity and venture capital firm currently investing out of its first fund with $250 million committed. S-Group is focused on companies within a broad range of industries, which includes technology, chemistry, engineering, financial services, and retail/consumer goods, located in Russia, the U.S., and Europe.

INNOVATION VENTURES, L.P.

Innovation Ventures is a licensed SBIC venture capital fund focused on investment opportunities in emerging technology businesses. Innovation Ventures, L.P., was formed by a team of seasoned venture managers and investors associated with the Delaware Innovation Fund, which has an eight-year history of successfully investing in and working with leading-edge technology entities throughout the mid-Atlantic region. For more information, visit www.innovationventures.com.

Discover More… about Centice Corporation

Pharmacy Advisory Board

Distinguished Pharmacy Advisory Board helps refine the PASS Rx system

Centice Corporation boasts a diverse Pharmacy Advisory Board to assist in fulfilling Centice’s mission statement and defining core values and long-term goals.

Barry Braverman

Pharmacy Owner, Barry’s Montville Pharmacy

Barry Braverman graduated from Rutgers College of Pharmacy in 1971 and became a New Jersey-licensed pharmacist in 1972. Seven years later, he founded Montville Pharmacy, which now employs 25. He has been on the national and regional advisory boards of Cardinal and was heavily involved in the testing and implementation of the Cardinal Inventory System, which is now used nationwide. Barry has also held consulting positions for companies such as 3PM, ScriptTech, Ohaus and Innovation.

Jimmy Jackson

Spoke Consulting, Inc.

Jimmy S. Jackson serves on advisory boards for schools of pharmacy at UNC, Campbell, South Carolina and UF. Jimmy is a past president and director of the Garner Chamber of Commerce. After graduating from the University of Mississippi School of Pharmacy in 1967, he began his career with Kerr Drug Stores and moved through the operational ranks. He was the Vice President of Pharmacy and Government Affairs at the time of Kerr’s acquisition by the J.C. Penney Company. Jimmy served in numerous positions of leadership with the NC Pharmaceutical Association and served as president in 1997. He served as vice president of pharmacy affairs for the Eckerd Corporation, and works closely with Boards of Pharmacy and Legislatures.

Jimmy served as president of the North Carolina Pharmaceutical Association for the 1997-98 term and was elected pharmacist of the year for 1998. On the national level Jimmy has chaired the State Govt. Affairs committee for the National Association of Chain Drug Stores and has received the NACDS Harold Pratt award 1997.

In 2008, the University of Florida School of Pharmacy faculty chose Mr. Jackson to receive their award for Distinguished Pharmacy Service and was also awarded an honorary PhD from Campbell University.

Mike James, R.Ph.

Owner, Person Street Pharmacy

Mike James graduated from Samford University in Birmingham, Ala., with a B.S. degree in Pharmacy. He is a member of the National Community Pharmacists Association, Association of Community Pharmacists, Fellow American College of Apothecaries, North Carolina Association of Pharmacists, Pro Care Association and the North Carolina Banking Commission. He is President of Person Street Pharmacy, Inc., in Raleigh, N.C., and President of Century Drug, Inc., of Deerfield Beach, Fla., as well as Governmental Affairs Director for North Carolina Mutual Wholesale Drug Company. He was elected to the board in 2003.

Currently residing in Raleigh, N.C., Mike is very involved with national government legislation and continually serves as an advocate for the retail independent pharmacist in Washington, D.C.

John Simmons

Retired Director, FDA

John Simmons recently retired from the FDA after 20 years of service. His most recent responsibilities were as Director, Division of Pre-Marketing Assessment II & Manufacturing Science in the Office of New Drug Quality Assessment. Some of his major achievements have been the review, inspection and approval of Gleevec, a new class of oncology drug, in just 45 days, which required collaborative and innovative approaches to working with a pharmaceutical manufacturer. He has also been involved with the review and approval of the first major combination products Mylotarg (a monoclonal antibody with a cytotoxic agent) and the Cypher drug eluting stent (a drug-device combo).

He has served in the Office of New Drug Chemistry, Office of Generic Drugs, Division of Cardio-Renal Drug Products and the Division of Biopharmaceutics. His current areas of interest include PAT and Combination Products. He has over 125 publications and presentations in the areas of analytical methodology to evaluate drugs in vitro and in vivo. Prior to his tenure with the FDA, he was on the faculty at the University of Pittsburgh, School of Pharmacy and the University of Kansas, School of Pharmacy, Center for Biomedical Research. He holds degrees from Temple University and the University of Pittsburgh.

Jim Stefanadis, R.Ph.

Outpatient Pharmacy Manager, Duke Hospital

Since 2004, Jim Stefanadis has been Outpatient Pharmacy Manager at Duke Hospital, where he supervises all pharmaceutical care responsibilities and staff management, ensures compliance with all regulatory practice standards, and participates in student and resident education. Prior to working for Duke Hospital, he held management positions at Harris-Teeter, Eckerd Drug and KERR Drug.

In addition to serving on the Centice Pharmacy Advisory Board, he serves as a board member for Cardinal Health Regional Advisory and Duke Health System Resource Advisory. Jim also serves on many committees, including Duke Hospital Compounding Oversight Committee and Duke Strength, Hope and Caring Committee. He is a member of the NC Association of Pharmacists Emergency Preparedness and the Orange County Board of Public Health Pharmacist, in addition to being Chair of the Orange County Clinical and Community Programs.

Mr. Stefanadis graduated from UNC Chapel Hill in 1984 with a BS in Pharmacy and completed research work with EPA published in Teratology in June 1985 and April 1987. He has won the Kerr Drug Store President’s Circle Store Manager of the Year Award in 1994 and became a PCCA Certified Compounding Pharmacist in 2000.

Discover More… about Centice Corporation

Our Business Partners

Discover More… about our mutually beneficial industry partnerships

Centice Corporation recognizes that collaboration is essential to developing, marketing and bringing new technology to the market. Centice has worked hard to cultivate relationships with like-minded, innovative companies with the belief that the patient will benefit in the long run.

Medi-Span

Medi-Span® is the leading provider of drug information for thousands of health care professionals worldwide. With more than 30 years experience, Medi-Span continues to offer authoritative drug databases in a variety of formats, including clinical decision support and disease suite modules, application programming interfaces and stand-alone software applications. In conjunction with superior implementation and experienced customer support, the Medi-Span product line is the perfect choice for those needing accurate, trusted, drug data that easily integrates into existing software applications. For more information, visit www.MediSpan.com.

Medi-Span is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Wolters Kluwer Health is a division of Wolters Kluwer, Wolters Kluwer Health is a division of Wolters Kluwer, a leading global information services and publishing company with annual revenues (2007) of €3.4 billion ($4.8 billion), maintains operations in over 33 countries across Europe, North America, and Asia Pacific and employs approximately 19,500 people worldwide. Visit www.wolterskluwer.com for information about our market positions, customers, brands, and organization.

NC Mutual Wholesale Drug Company

In 1952, Mutual Drug was formed by independent pharmacists. The company’s goal then, and now, is to provide services needed to ensure member stores’ success. Their commitment to this success includes providing equal pricing, regardless of volume, as well as programs and services designed for the needs of an independent pharmacy. For more information, please visit www.mutualdrug.com.

Sanmina-SCI Corporation

Sanmina-SCI Corporation is a leading electronics contract manufacturer serving the fastest-growing segments of the global Electronics Manufacturing Services (EMS) market. Recognized as a technology leader, Sanmina-SCI provides end-to-end manufacturing solutions, delivering unsurpassed quality and support to OEMs primarily in the communications, defense and aerospace, industrial and semiconductor systems, medical instrumentation, multimedia, enterprise computing and storage, and automotive technology sectors. Sanmina-SCI has facilities strategically located in key regions throughout the world. For more information, please visit www.sanmina-sci.com.

VisionPoint Marketing

VisionPoint Marketing is a marketing solutions agency providing integrated programs – interactive and/or traditional tactics – for mid-sized organizations in a variety of industries including higher education, healthcare, biotech/life sciences, pharmaceutical, high tech, and business services. For more information, please visit www.visionpointmarketing.com.

Discover More… about Centice Corporation

Leadership

Proven leadership guides Centice Corporation’s pursuit of innovative products and services

Executive Leadership Team
Board of Directors
Pharmacy Advisory Board

Executive Leadership Team

Arthur Bergens

Chief Financial & Administration Officer

John Davis

Vice President, Sales and Marketing

Executive Leadership Bios

Back to Executive Team

Arthur Bergens

Chief Financial & Administration Officer

Back to Executive Team

John Davis

Vice President, Sales & Marketing

Back to Executive Team

Prasant Potuluri, Ph. D.

Chief Technology Officer

Back to Executive Team

Board of Directors

Scott Albert

Chairman of the Board
General Partner, The Aurora Funds, Inc.

Scott Albert co-founded The Aurora Funds with Jeff Clark in 1994, after already spending nearly a decade in the venture capital industry. Having also spent time as an entrepreneur, he wanted to create an entrepreneurs-friendly venture capital firm that could offer hands-on support and guidance, in addition to funding. Today, he leads the IT investment team at Aurora and also oversees much of the day-to-day management of the firm, working closely with the CFO and Controller. He tries to make sure that everyone on the team does everything they can to support Aurora’s portfolio companies. He personally spends more than 50 percent of his time helping entrepreneurs create their go-to-market strategy, raise additional funds, address customer-oriented issues and develop exit strategies. He spends the remainder of his time dealing with internal operational issues, identifying and evaluating new deals and supporting entrepreneurial efforts of the greater RTP community. Prior to forming The Aurora Funds, Scott was the Chief Investment Officer of the North Carolina Technological Development Authority, Inc. (“NCTDA”), a state-funded corporation that supports technology-based entrepreneurial companies in North Carolina. While there, he led the new venture investment efforts and performed portfolio company monitoring for the NCTDA’s extensive statewide portfolio. Prior to serving at the NCTDA, he was at Criterion Venture Partners in Houston, Texas, as a General Partner for a $30 million pool of capital, and with Golder, Thoma and Cressey, in Chicago. In addition, he has served as President of a venture-backed start-up company. Before entering the venture capital industry, he was a consultant for Booz, Allen and Hamilton. During his venture capital career, Scott has helped close more than 40 investment deals, including a broad range of Information Technology and Life Science companies. Scott currently serves on the boards of several Aurora portfolio companies, including ALN Medical Management, Centice, psiloQuest, StrikeIron, Trivirix, Visitar, and WiDeFi. Scott was previously on the boards of Solution Technology (acquired by Rodel) and DataFlux (acquired by SAS) and led the investment in Blackboard (NASDAQ: BBBB). Scott has a bachelor’s of science in Engineering from Duke University and a MBA from the University of Chicago.

Tom Scholl

General Partner, Novak Biddle Venture Partners

Tom Scholl is a successful entrepreneur and investor with experience sitting on both sides of the boardroom table. He has more than 25 years of experience in communications systems, equipment, chipsets and software, and has been active in the high-tech start-up scene in the Washington metro area for more than15 years. Tom currently sits on the boards of portfolio companies Centice, Paratek, Princeton Optronics, Sennari, Command Information, Fiberzone Networks and Digital Bridge. In 1990, Tom founded Telogy Networks, a leader in providing embedded communications software products for wireless and IP networks. Telogy’s award-winning products were proven market successes with world-class customers such as Cisco, Motorola, Samsung, Nortel, Alcatel and NEC. In 1998, Motorola purchased Telogy’s digital cellular technology and development team for over $40M, and in 1999, Texas Instruments purchased Telogy as the leader in embedded VOIP software for over $700M. Prior to joining Novak Biddle, Tom co-founded and became chairman of Cognio, a developer of spectrum management and MIMO technology for short-range wireless applications. In 1995, he was recognized as the Joseph A. Sciulli “Entrepreneur of the Year” by the Maryland High Technology Council. Prior to Telogy, Tom was Senior Vice President of Engineering at Hughes Network Systems, a combination of M/A-Com DCC and Linkabit. Tom is a member of the Board of Trustees at the University of Maryland and is also Chairman of the Board of Visitors at the Clark School of Engineering. Tom has patents relating to software, the Internet, and digital telephone systems, and he is the author of “Packet Switching” in McGraw Hill’s Electronic Communications Handbook. He’s a member of IEEE and ACM, and he is an alumnus of Purdue University and the Executive Management program at MIT Sloan School.

Aidar Gabidullin

Oscriva LtdBio
~~BIO AND TO FOLLOW.~~

Alan Levin

Pharmacy Industry Veteran

Alan Levin was formerly Chairman, President and CEO of Happy Harry’s, a leading regional drugstore chain with 2,700 employees and stores in Delaware, Maryland, Pennsylvania and New Jersey, until it was acquired by the Walgreen Company in 2006. Alan is a graduate of Tulane University and the Delaware Law School of Widener University. He previously served in the Delaware Department of Justice as a Deputy Attorney General and as Executive Assistant and Counsel to United States Senator William V. Roth, Jr. He assumed the position of Chairman, President and Chief Executive Officer of Happy Harry’s when his father and founder of the business, Harry Levin, passed away in 1987. During his tenure, the company grew from 19 to 76 stores. Alan is also a past Chairman of the National Association of Chain Drug Stores.

David Brady, PhD

Chief Scientist and Co-Founder, Centice Corporation

David Brady holds a B.A. in physics and mathematics from Macalester College and M.S. and Ph D degrees in applied physics from the California Institute of Technology. He was on the faculty of electrical and computer engineering at the University of Illinois in Urbana-Champaign from 1990 until joining the Duke faculty in 2001. Dr. Brady’s research focuses on computational optical sensors. He leads the DISP group (www.disp.duke.edu), which builds interferometric and coherence sensors for 3-D microscopy, Raman spectroscopy for biosensors, interferometric telescopy and biometric sensor networks. At the Fitzpatrick Center, David focuses on undergraduate and graduate education in photonics, with a particular emphasis on optics as an information science and optics education as a bridge between physical and digital systems.

Discover More… about Centice Corporation

About Us

Discover More… about Centice Corporation’s history and background

In 2004, Centice was founded to commercialize patented and patent-pending computational sensor technology originally developed at Duke University.

Although our technology has multiple applications, Centice has focused on the development of the PASS Rx system – a pharmaceutical verification product. The PASS Rx system improves the verification process for dispensed medications, thereby increasing patient safety, reducing human error and streamlining the pharmaceutical dispensing process.

Our unique sensor technologies impact the health care industry by increasing efficiency, optimizing workflow, providing peace of mind to healthcare providers and boosting patient confidence.